According to a presentation at the World Congress of Cardiology, people with hypertension (high blood pressure) could reduce their risk of dying from cardiovascular disease (CVD) or all-cause mortality to a level equivalent a reduction of 40~50 mmHg in blood pressure, simply by exercising. High blood pressure is one of the major preventable risk factors for premature CVD deaths worldwide, contributing to about 50% of all CVDs. The risk of developing CVD doubles for every 10-point increase in diastolic blood pressure, and if left untreated, hypertension can dramatically raise a person's risk of developing CVD. Hypertension treatment has been linked to reducing the risk of stroke by 35 to 40%, as well as reducing the risk of a heart attack by at least 16%. The researchers conducted a prospective study that involved 434, 190 Taiwanese people over a 12-year period, of which 54% were classified as being inactive, 22% as having a low level of activity and 24% as having a medium or higher activity level.
The first fully biodegradable coronary artery stent implanted in humans proved safe in a 10-year study published in Circulation, an American Heart Association journal. Stents are mesh tubes inserted into coronary arteries to help prop them open and allow for blood flow to the heart muscle. The biodegradable Igaki-Tamai stent is used in nine European Union countries and Turkey- but not in the United States - to treat peripheral artery disease (PAD), the disorder which results from fatty deposits that narrow leg arteries. However, no countries have approved the Igaki-Tamai stent for treating clogged heart arteries. "We have needed this long-term clinical data to clarify the coronary safety of the stent, " said Kunihiko Kosuga, M.D., Ph.D., co-author of the study and director of cardiology at Shiga Medical Center for Adults in Moriyama City, Japan.
Harvard researchers suggest optimism, happiness and other positive emotions may help protect heart health and lower the risk of heart attacks, strokes and other cardiovascular events. It also appears that these psychological well-being factors slow the progress of cardiovascular disease. The findings are the result of the first and largest systematic review of its kind, and are reported in the 16 April online issue of Psychological Bulletin, by lead author Julia Boehm, a research fellow, and senior author Laura Kubzansky, an associate professor, in the department of society, human development, and health, at the Harvard School of Public Health (HSPH) in Boston, Massachusetts. According to the American Heart Association, one person dies from cardiovascular disease every 39 seconds in the United States.
The Indian Heart Watch (IHW) study has revealed the truth behind the prevalence, awareness, treatment and control of key risk factors that are driving the country's growing cardiovascular disease (CVD) epidemic, in a first-of-a-kind presentation of data at the World Congress of Cardiology. The study assessed the prevalence of different "lifestyle" and biological CVD risk factors across the country - and results show that these risk factors are now at higher levels in India than in developed countries and regions such as the USA and Western Europe. Seventy-nine per cent of men and 83 per cent of women were found to be physically inactive, while 51 per cent of men and 48 per cent of women were found to have high fat diets. Some 60 per cent of men and 57 per cent of women were found to have a low intake of fruit and vegetables, while 12 per cent of men and 0.
A lot of people were skeptical when two young California-based researchers set out more than a decade ago to create a completely human-derived alternative to the synthetic blood vessels commonly used in dialysis patients. Since then, they've done that and more. "There were a lot of doubts in the field that you could make a blood vessel, which is something that needs to resist pressure constantly, 24-7, without any synthetic materials in it, " explains Nicolas L'Heureux, a co-founder and the chief scientific officer of Cytograft Tissue Engineering Inc. "They didn't think that was possible at all." But they were wrong. Cytograft, which L'Heureux and Todd McAllister co-founded in 2000, has indeed developed vessels that are "completely biological, completely human and living, which is the Cadillac of treatments .